Corbus Pharmaceuticals I... (CRBP)
6.90
-0.65 (-8.61%)
At close: Mar 03, 2025, 3:59 PM
6.96
0.87%
After-hours: Mar 03, 2025, 04:00 PM EST
Corbus Pharmaceuticals Balance Sheet Statement
| Year | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 | FY16 | FY15 | FY14 | FY13 | FY12 |
| Cash & Equivalents | 13.72M | 17M | 25.01M | 85.43M | 31.75M | 41.75M | 62.54M | 14.99M | 12.34M | 6.26M | 303.02K | 542.48 |
| Short-Term Investments | 7.18M | 42.19M | 72.64M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Long-Term Investments | n/a | 477.43K | 477.43K | 669.9K | n/a | n/a | n/a | 50K | 36.38K | n/a | n/a | n/a |
| Other Long-Term Assets | 690.23K | 155.35K | 46.38K | 234.04K | 84.97K | 43.82K | 40.78K | n/a | n/a | 13.73K | n/a | n/a |
| Receivables | n/a | n/a | n/a | 2.58M | 2.68M | n/a | n/a | 1.33M | n/a | n/a | n/a | n/a |
| Inventory | n/a | n/a | n/a | 350K | -2.68M | n/a | n/a | 0.00 | n/a | n/a | n/a | n/a |
| Other Current Assets | 2.64M | 984.09K | 2.56M | 4.06M | 3.72M | 4.98M | 2.97M | 1.08M | 376.51K | 270.56K | 2.5K | 2.50 |
| Total Current Assets | 23.55M | 60.18M | 100.2M | 92.07M | 38.15M | 44.24M | 65.5M | 17.4M | 12.71M | 6.53M | 305.52K | 544.98 |
| Property-Plant & Equipment | 4.04M | 5.5M | 7M | 9.32M | 10.9M | 2.71M | 1.43M | 435.25K | 124.14K | 54.04K | n/a | n/a |
| Goodwill & Intangibles | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Total Long-Term Assets | 4.73M | 6.13M | 7.53M | 10.22M | 10.99M | 2.75M | 1.47M | 485.25K | 160.51K | 67.77K | n/a | n/a |
| Total Assets | 28.27M | 66.31M | 107.73M | 102.29M | 49.14M | 46.99M | 66.98M | 17.89M | 12.88M | 6.6M | 305.52K | 544.98 |
| Account Payables | 3.18M | 2.17M | 1.78M | 7.38M | 11.09M | 6.35M | 3.13M | 3.42M | 1.31M | 344.16K | 181.47K | 49.62 |
| Deferred Revenue | 6.38M | n/a | 10.09M | 22.01M | n/a | 1.46M | n/a | 1.94M | 1.59M | n/a | 140.63K | n/a |
| Short-Term Debt | 17.65M | 4.43M | 5M | 2.72M | 1.35M | 394.68K | 332.86K | 271.76K | -400.26K | 144.39K | 306.83K | n/a |
| Other Current Liabilities | 11.07M | 6.04M | 10.23M | 21.8M | 22.45M | 9.89M | 4.74M | 3.27M | 562.28K | 249.49K | 160.56K | 227.15 |
| Total Current Liabilities | 31.89M | 12.64M | 17.01M | 31.9M | 34.89M | 18.09M | 8.2M | 8.9M | 3.63M | 738.04K | 648.87K | 276.78 |
| Long-Term Debt | 3.24M | 20.66M | 21.59M | 25.12M | 8.1M | n/a | n/a | 4.63K | n/a | n/a | 331.24K | 466.59 |
| Other Long-Term Liabilities | 44.41K | 22.2K | 22.2K | n/a | n/a | 1.38M | 989.92K | 65.72K | n/a | n/a | 1.11M | -466.59 |
| Total Long-Term Liabilities | 3.28M | 20.68M | 21.61M | 25.12M | 8.1M | 1.38M | 989.92K | 70.36K | 260.26K | n/a | 1.44M | 466.59 |
| Total Liabilities | 35.18M | 33.32M | 38.62M | 57.02M | 42.98M | 19.47M | 9.19M | 8.97M | 3.89M | 738.04K | 2.09M | 743.36 |
| Total Debt | 20.88M | 25.09M | 26.59M | 26.84M | 9.45M | 394.31K | 332.86K | 276.39K | 162.02K | 144.39K | 638.08K | n/a |
| Common Stock | 442.00 | 417.00 | 12.52K | 9.88K | 6.47K | 5.72K | 5.56K | 4.47K | 3.76K | 2.59K | 696.00 | 0.70 |
| Retained Earnings | -436.68M | -392.08M | -349.73M | -304.09M | -192.82M | -121.37M | -65.7M | -33.28M | -13.28M | -4.43M | -1.89M | -1.28K |
| Comprehensive Income | -1.56K | -126.09K | -62.45K | n/a | n/a | -666.58K | -363.89K | -108.24K | -54.35K | -10.4K | -1.11M | n/a |
| Shareholders Equity | -6.9M | 32.99M | 69.11M | 45.27M | 6.16M | 27.52M | 57.78M | 8.92M | 8.99M | 5.86M | -1.78M | -198.38 |
| Total Investments | 7.18M | 42.19M | 72.64M | 669.9K | n/a | n/a | n/a | 50K | 36.38K | n/a | n/a | n/a |